These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 28090013

  • 1. [Significance of monitoring trough plasma concentration levels for invasive fungal infection prophylaxis with itraconazole oral solution in patients with hematological malignancies: a prospective study].
    Kawano I, Matsumoto K, Jiromaru T, Jinnochi F, Semba Y, Sugio T, Sakamoto K, Saito N, Yoshida S, Henzan H, Takase K, Morita K, Eto T.
    Rinsho Ketsueki; 2016; 57(12):2475-2480. PubMed ID: 28090013
    [Abstract] [Full Text] [Related]

  • 2. Comparison of long-term and short-term administration of itraconazole for primary antifungal prophylaxis in recipients of allogeneic hematopoietic stem cell transplantation: a multicenter, randomized, open-label trial.
    Lin R, Xu X, Li Y, Sun J, Fan Z, Jiang Q, Huang F, Zhou H, Nie D, Guo Z, Mao Y, Xiao Y, Liu Q.
    Transpl Infect Dis; 2014 Apr; 16(2):286-94. PubMed ID: 24593273
    [Abstract] [Full Text] [Related]

  • 3. Plasma Concentration of Itraconazole in Patients With Hematologic Malignancies Treated With Itraconazole Oral Solution.
    Marumo A, Miyawaki S, Dan N, Ishiyama K.
    Ther Drug Monit; 2017 Jun; 39(3):229-234. PubMed ID: 28445212
    [Abstract] [Full Text] [Related]

  • 4. [Itraconazole capsules as antifungal prophylaxis for neutropenic patients with hematological malignancies from a single institution].
    Toubai T, Tanaka J, Ota S, Kato N, Umehara S, Kahata K, Toyoshima N, Asaka M, Imamura M.
    Jpn J Antibiot; 2005 Dec; 58(6):507-17. PubMed ID: 16521343
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Prophylaxis of invasive fungal infection with different administration regimens of itraconazole in patients with acute myeloid leukemia: a report from a randomized, controlled trial].
    Liu X, Huang Y, Yang DL, Wei JL, He Y, Ma QL, Pang AM, Feng SZ, Han MZ.
    Zhonghua Xue Ye Xue Za Zhi; 2013 Jun; 34(6):502-6. PubMed ID: 23827107
    [Abstract] [Full Text] [Related]

  • 16. Effective plasma concentrations of itraconazole and its active metabolite for the treatment of pulmonary aspergillosis.
    Nakamura Y, Matsumoto K, Sato A, Morita K.
    J Infect Chemother; 2020 Feb; 26(2):170-174. PubMed ID: 31481305
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Prophylaxis of fungal infection in patients with hematologic neoplasms and severe neutropenia after high-dose chemotherapy].
    Minenko SV, Zhukov NV, Chimishkian KL, Sokolova EN, Ptushkin VV.
    Antibiot Khimioter; 2004 Feb; 49(8-9):52-6. PubMed ID: 15727147
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.